MP47: Kidney Cancer: Epidemiology & Evaluation/Staging/Surveillance III

Sunday, May 15, 2022

2:45 PM – 4:00 PM

Location: Room 228

Poster Session Moderator(s)

Allan Pantuck, MD

UCLA Institute of Urologic Oncology
SS

Stephen Savage, MD

Professor and Vice Chairman of Urology
Medical University of South Carolina
John Pattaras, MD

M.D.
Emory University School of Medicine

Presentations:

2:45 PM – 4:00 PM

MP47-01: Development of individual level inference available explainable artificial intelligence model for cancer-specific survival after nephrectomy in renal cell carcinoma patients
Poster Presenter: Jungyo Suh, MD
2:45 PM – 4:00 PM

MP47-02: Machine learning approach to predict pT3a upstaging of clinically localized renal cell carcinoma and oncological outcomes after surgery (UroCCR 15 study).
Poster Presenter: Astrid Boulenger De Hauteclocque, MD – CHU Bordeaux
2:45 PM – 4:00 PM

MP47-03: Mayo Clinic Validation of The American Urologic Association Risk Groups for Localized Renal Cancer
Poster Presenter: Andrew J. Zganjar, MD
2:45 PM – 4:00 PM

MP47-04: Validation of a 22-Gene Epithelial-Mesenchymal Transition (EMT) Prognostic Signature in Clear Cell Renal Cell Carcinoma
Poster Presenter: Brittney Cotta
2:45 PM – 4:00 PM

MP47-05: Stimulated Raman Histology Allows for Real Time Determination of the Adequacy of Renal Mass Biopsy and Identify Malignant Subtypes of Renal Cell Carcinoma
Poster Presenter: Miles Mannas, MD, FRCSC
2:45 PM – 4:00 PM

MP47-06: Assessing renal mass management of patients with increased comorbidities: Results from a statewide registry
Poster Presenter: Alison C. Levy, MD – Henry Ford Hospital
2:45 PM – 4:00 PM

MP47-07: Defining the Impact of Percutaneous Renal Biopsy on Risk of Intervention for Patients on Active Surveillance for Small Renal Masses
Poster Presenter: Song Jiang, MD, PHD
2:45 PM – 4:00 PM

MP47-08: Surgical Delay After Biopsy and Risk of Upstaging for Clinical T1a Renal Cell Carcinoma
Poster Presenter: Leilei Xia, MD
2:45 PM – 4:00 PM

MP47-09: The added value of histological subtype in the prediction of oncologic outcomes in patients with non-metastatic papillary renal cell carcinoma
Poster Presenter: Gianfranco Baiamonte
2:45 PM – 4:00 PM

MP47-10: Differences in predictive ability of CRP and De Ritis Ratio for Outcomes in Renal Cell Carcinoma.
Poster Presenter: John Matthew Perry, BS
2:45 PM – 4:00 PM

MP47-11: Differential Association of Body Mass Index on Survival Outcomes in Renal Cell Carcinoma: Impact of Tumor Histology
Poster Presenter: Arman Walia
2:45 PM – 4:00 PM

MP47-12: Frailty status predicts worse postoperative and long-term oncologic outcomes in patients treated with partial nephrectomy for small renal masses
Poster Presenter: Giuseppe Rosiello, MD – San Raffaele Hospital
2:45 PM – 4:00 PM

MP47-13: Muscle Mass Change Using Linear Measurement Analysis after Nephrectomy for pT3 Renal Cell Carcinoma is Associated with Mortality
Poster Presenter: Alexandra Medline, MD,MPH
2:45 PM – 4:00 PM

MP47-14: The Role of Combined Sarcopenia and Albumin in the Surgical Prognostication of Locally Advanced Renal Cell Carcinoma with Venous Tumor Thrombus
Poster Presenter: Eric Midenberg, MD, BS
2:45 PM – 4:00 PM

MP47-15: Impact of Diabetes Mellitus on Functional Decline and Non-Cancer Mortality in Renal Cell Carcinoma: Analysis of the International Marker Consortium (INMARC)
Poster Presenter: Ava Saidian, MD
2:45 PM – 4:00 PM

MP47-16: Decline to "Severe" CKD-S is a predictive marker for all-cause and non-cancer mortality in Renal Cell Carcinoma: analysis of the International Marker Consortium for Renal Cancer (INMARC)
Poster Presenter: Mimi Vu Nguyen, BS
2:45 PM – 4:00 PM

MP47-17: Impact of Patient and Lifestyle Factors in Patients with Stage III & IV Renal Cancer: A Danish Nationwide Study
Poster Presenter: Nessn Azawi
2:45 PM – 4:00 PM

MP47-18: Sustainable multidisciplinary team referral for non-metastatic renal cell carcinoma: a survival-based recommendation
Poster Presenter: Giuseppe Basile, MD
2:45 PM – 4:00 PM

MP47-19: Underrepresentation of Hispanics and American Indian/Alaska Natives in the National Cancer Database
Poster Presenter: Juan F. Javier-Desloges, MD
2:45 PM – 4:00 PM

MP47-20: Universal Germline Genetic Testing of Patients with Newly Diagnosed Upper Tract Urothelial Carcinoma: An Interim Analysis
Poster Presenter: Craig Labbate, MD – UT MD Anderson Cancer Center